RAD50
Synonym(s): hRad50, RAD50-2
Locus: 5q31.1
Protein: DNA repair protein RAD50
Disorders
Tests
| CancerNext method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
| BreastNext method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
| Breast and Ovarian Cancer Test method(s): ◦ Genotyping (Microarray, Beads, etc.) ◦ Sequencing, Next Gen Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
| Breast Cancer Panel method(s): ◦ Sequencing, Next Gen ApolloGen, Inc. - Irvine, CA, USA |
| NGS of genes: BLM, GPC3, NBN, NSD1, RAD50, WT1. method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Next Gen Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
| Chromosome Breakage Disorders NGS Panel method(s): ◦ Sequencing, Next Gen Bristol Genetics Laboratory - Bristol, United Kingdom |
| NGS and Sanger sequencing of the RAD50 gene method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
| Nijmegen breakage syndrome like disorders method(s): ◦ Sequencing, Capillary (Sanger) Cologne University, Institute of Human Genetics - Cologne, Germany |
| CancerNext - Expanded method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
| OvaNext method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
| Breast and Ovarian Cancer - extended Diagnostic Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
| Somatic Tumor Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
| OncoRisk (NGS panel for 49 genes) method(s): ◦ Sequencing, Next Gen CGC Genetics - Porto, Portugal |
| Nijmegen breakage syndrome-like disorder (sequence analysis of RAD50 gene) method(s): ◦ Sequencing, Capillary (Sanger) CGC Genetics - Porto, Portugal |
| Breast and Ovarian Cancer: Sequencing and Deletion/Duplication Panel method(s): ◦ Del/Dup (CNV) CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
| Focus Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
| RAD50 method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
| Breast Cancer Focus Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
| Comprehensive Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
| Breast Cancer Comprehensive Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
| Comprehensive Hereditary Breast-Ovarian Cancer Panel method(s): ◦ Sequencing, Next Gen NeoGenomics Laboratories - Fort Myers, FL, USA |
| CustomNext-Cancer method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
TAT: 3-4 weeks Hereditary Breast and Ovarian Cancer via the RAD50 Geneprice: $690.00 method(s): ◦ Del/Dup (CNV) PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-5 weeks Hereditary Breast and Ovarian Cancer Syndrome - HBOC EXPANDED Sequencing and Deletion/Duplication Panelprice: $1,190.00 method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-5 weeks Hereditary Breast and Ovarian Cancer via the RAD50 Geneprice: $990.00 method(s): ◦ Sequencing, Next Gen PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3 weeks Otogenetics Hereditary Cancers (Breast, Gyn, GI)price: $795.00 method(s): ◦ Sequencing, Next Gen Otogenetics Corporation - Atlanta, GA, USA |
| Inherited Cancer Screen method(s): ◦ Sequencing, Next Gen Counsyl, Inc., Counsyl - South San Francisco, CA, USA |
| CEN4GEN Comprehensive Hereditary Cancer Syndrome: Sequencing Panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
| Hereditary breast and ovarian cancer syndrome, RAD50 related method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) Centogene AG, Rare Disease Company - Rostock, Germany |
| Breast ovarian cancer panel PLUS method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Centogene AG, Rare Disease Company - Rostock, Germany |
| Breast and Ovarian Cancer 21 Gene Panel method(s): ◦ Sequencing, Next Gen Genomic Research Center, Shahid Beheshti University of Medical Sciences - Tehran, Iran, Islamic Republic of |
TAT: 1-3 weeks Invitae Breast and Gyn Cancers Panelprice: $1,500.00 method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks Invitae Breast Cancer Panelprice: $1,500.00 method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks Invitae Multi-Cancer Panelprice: $1,500.00 method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks Invitae Common Hereditary Cancers Panel (Breast, Gyn, GI)price: $1,500.00 method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
| Comprehensive Hereditary Cancer Panel method(s): ◦ Sequencing, Next Gen Baylor Miraca Genetics Laboratories - Houston, TX, USA |
| Ovarian cancer panel, targeted method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Centogene AG, Rare Disease Company - Rostock, Germany |
| Comprehensive Hereditary Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
| Hereditary Breast and Ovarian Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
| Hereditary Gynecological Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
| Hereditary Breast and Gynecological Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
| Comprehensive Hereditary Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
| Hereditary Breast and Ovarian Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
| Hereditary Gynecological Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
| Hereditary Breast and Gynecological Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
| Phosphorus Common / High-Risk Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |
| Phosphorus Pan Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |
| Phosphorus Breast Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |